Ilika and Cirtec Medical Reach Key Step in Micro-Battery Manufacturing

Ilika plc (LSE:IKA) has marked an important step forward in its collaboration with Cirtec Medical, successfully completing the manufacturing process qualification for its Stereax micro-batteries at Cirtec’s facility in the United States. With this milestone achieved, production is now moving into the phase of product testing and initial shipments to customers. The development strengthens opportunities for next-generation miniaturized power solutions, particularly for implantable medical technologies.

By merging Ilika’s innovation in solid-state battery design with Cirtec’s specialized manufacturing capabilities, the partnership is well positioned to address the rising demand for compact, high-performance batteries that support advanced medical implants.

Despite the technical progress, Ilika continues to face notable financial headwinds and valuation pressures. These challenges are partly balanced by encouraging corporate developments and ongoing advances in its technology pipeline. The company’s ability to secure funding and move its products closer to commercialization remains critical to its outlook.

About Ilika plc

Ilika is recognized internationally for its expertise in solid-state battery innovation across multiple industries, including electric mobility, medical devices, and consumer electronics. The company’s portfolio includes two core product families: Stereax micro-batteries, tailored for miniature implants and IoT applications, and Goliath large-format cells, developed for electric vehicles and cordless appliances. Operating primarily through a licensing model, Ilika provides its intellectual property to original equipment manufacturers and production partners to bring its technology to market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.